COVID-19 Clinical Trials

A listing of COVID-19 medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 76 clinical trials
Study of a Live rNDV Based Vaccine Against COVID-19

This is a Phase 1, open-label, non-randomized, dose-escalation study using three doses and two schemes of administration of a recombinant vaccine against SARS-CoV-2 based on a viral vector (Newcastle Disease virus) in 90 healthy volunteers at a single research site in Mexico City.

  • 0 views
  • 02 Jun, 2021
  • 1 location
Hyperpolarized 129Xe MRI of Survivors of COVID-19

The purpose of this study is to evaluate pulmonary function of patients recovering from mild, moderate, and severe COVID-19 disease using hyperpolarized 129Xe MRI.

  • 0 views
  • 06 Mar, 2021
  • 1 location
Safety and Immunogenicity of Two Different Strengths of the Inactivated COVID-19 Vaccine ERUCOV-VAC

The objective is to determine the safety and immunogenicity of two different strengths (3 g and 6 g) of an inactivated COVID 19 Vaccine compared to placebo so that to demonstrate the safety and

  • 0 views
  • 28 Jan, 2021
  • 1 location
DISmantling COvid iNduced Neutrophil ExtraCellular Traps (DISCONNECT-1)

This is a pilot study to investigate the safety and feasibility of rhDNase1 and its impact on neutrophil extracellular traps (NETs) in COVID-19 infected patients.

  • 0 views
  • 27 Jan, 2021
  • 1 location
Safety and Immunogenicity of the Inactivated Ko ak-19 Inaktif Adjuvanl COVID-19 Vaccine Compared to Placebo

The objective of this study is to determine the safety and immunogenicity of two different strengths (4 g and 6 g) of an inactivated COVID-19 Vaccine compared to placebo so that to demonstrate

  • 0 views
  • 21 Apr, 2021
  • 1 location
Study of Intravenous Administration of Allogeneic Adipose Stem Cells for COVID-19

This study is designed rapidly assess safety and preliminary efficacy in hospitalized patients with COVID-19 respiratory distress to provide clinical guidance for possible wider use in treating

  • 0 views
  • 01 Feb, 2021
  • 1 location
Trial of Famotidine & N-Acetyl Cysteine for Outpatients With COVID-19

The purpose of this trial is to assess the safety and toxicity profile of the combination of famotidine and oral n-acetyl cysteine in adult outpatients with newly diagnosed SARS-CoV-2 infection.

  • 0 views
  • 20 Mar, 2021
  • 3 locations
Study of TB006 in Outpatient Patients With Mild to Moderate COVID-19

TB006, a monoclonal antibody, is an anti-inflammatory and anti-fibrotic agent that reduces the severity of underlying diseases in COVID-19 patients. The primary objective of TB006 treatment is

  • 0 views
  • 04 Jun, 2021
  • 3 locations
A Study of Ad26.COV2.S in Healthy Adults (COVID-19)

The purpose of this study is to assess the safety and reactogenicity of Ad26.COV2.S (0.3 milliliter [mL] versus 0.5 mL) and to demonstrate non-inferiority (NI) of Ad26.COV2.S (0.3 mL versus 0.5 mL), 28 days after vaccination.

  • 0 views
  • 09 Jun, 2021
  • 1 location
To Evaluate the Safety and Immunogenicity of Vaccine Candidate Against COVID-19 in Healthy Adults

volunteers 18 to 45 (inclusive) years old, vaccinated or not by authorized COVID-19 vaccine. Study will be open label and will be randomized 1:1 in two parallel study arms receiving either one single

  • 0 views
  • 16 Jun, 2021
  • 1 location